Abstract
Risk factors for corneal transplantation failure include both immunologic factors, such as graft rejection, corneal neovascularization, and peripheral anterior synechiae, as well as non-immunologic factors, such as ocular surface disorders (OSD) and glaucoma. This review highlights the necessity of having healthy ocular surface epithelia, tears, and eyelids. It presents different types of OSD, their underlying pathology, and their impact on native cornea and corneal grafts. In addition, a range of proposed donor and surgical factors influencing surface integrity following corneal transplant are addressed. Current medical and surgical research, both pre- and post-operative that promise to further improve the outcome of corneal grafts in the context of OSD are discussed.
Similar content being viewed by others
References
Lemp MA (1989) The surface of the corneal graft: in vivo color specular microscopic study in the human. Tr Am Ophthalmol Soc 87:619–657
Rolando M, Zierhut M (2001) The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol 45(suppl 2):S203–S210
Virenders SS, Tseng SCG (2001) New perspectives in ocular surface disorders. an integrated approach for diagnosis and management. In J Ophthalmol 49(3):153–168
Xu K-P, Yagi Y, Toda I, Tsubota K (1995) Tear function index: a new measure of dry eye. Arch Ophthalmol 113:84–88
Tsubota K, Satake Y, Shimazaki J (1996) Treatment of severe dry eye. Lancet 348:123
Tsubota K, Yamada M, Urayama K (1994) Spectacle side panels and moist inserts for the treatment of dry-eye patients. Cornea 13(3):197–201
Pflugfelder SC, Solomon A, Stern ME (2000) The diagnosis and management of dry eye: a twenty-five-year review. Cornea 19(5):644–649
Prydal JI, Artal P, Woon H, Campbell FW (1992) Study of human precorneal tear film thickness and structure using laser interferometry. Invest Ophthalmol Vis Sci 33(6):2006–2011
Van Setten GB, Schultz GS (1994) Transforming growth factor alpha is a constant component of tear fluid. Graefes Arch Clin Exp Ophthalmol 232(9):523–526
Van Setten GB, Viinikka L, Tervo T (1989) Epidermal growth factor is a constant component of normal human tear fluid. Graefes Arch Clin Exp Ophthalmol 227(2):184–187
Li Q, Weng J, Mohan RR, Bennett GL, Schwall R, Wang ZF, Tabor K, Kim J, Hargrave S, Cuevas KH, Wilson SE (1996) Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea. Invest Ophthalmol Vis Sci 37(5):727–739
Kinoshita S, Kiorpes T, Friend J, Thoft RA (1982) Limbal epithelium in ocular surface wound healing. Invest Ophthalmol Vis Sci 23(1):73–80
Tseng SCG (1989) Concept and application of limbal stem cells. Eye 3(pt 2):141–157
Tsubota K, Toda I, Saito H, Shinozaki J (1995) Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders. Ophthalmology 102(10):1486–1496
Dua HS, Joseph A, Shanmuganathan VA, Jones RE (2003) Stem cell differentiation and the effects of deficiency. Eye 17:877–885
Charukamnoetkanok P (2006) Corneal stem cells: bridging the knowledge gap. Semin Ophthalmol 21:1–7
Dua HS, Azuara-Blanco A (2000) Limbal stem cells of the corneal epithelium. Surv Ophthalmol 44(5):415–425
Alldredge OC, Krachmer JH (1981) Clinical types of corneal transplant rejection—their manifestations, frequency, preoperative correlates, and treatment. Arch Ophthalmol 99:599–604
Ma DH, Tsai RJ, Chu WK, Kao CH, Chen JK (1999) Inhibition of vascular endothelial cell morphologenesis in cultures by limbal epithelial cells. Invest Ophthalmol Vis Sci 40(8):1822–1828
Thoft RA, Friend J (1983) The X, Y, Z hypothesis of corneal epithelial maintenance. Invest Ophthalmol Vis Sci 24(10):1442–1443
Holland EJ, Shwartz GS (1996) The evolution of epithelial transplantation for severe ocular surface disease and a proposed classification system. Cornea 15(6):549–556
Wirtschafter JD, Ketcham JM, Weinstock RJ, Tabesh T, McLoon LK (1999) Mucocutaneous junction as the major source of replacement palpebral conjunctival epithelial cells. Invest Ophthalmol Vis Sci 40(13):3138–3146
Stulting RD, Waring GO III, Bridges WZ, Cavanagh HD (1988) Effects of donor epithelium on corneal transplant survival. Ophthalmology 95(6):803–812
Feiz V, Mannis MJ, Kandavel G, McCarthy M, Izquierdo L, Eckert M, Schwab I, Torabian S, Wang J-L, Wang W (2001) Surface keratopathy after penetrating keratoplasty. Tr Am Ophthalmol Soc 99:159–170
Machado RAM, Mannis MJ, Mandel HA, Feiz V, Schwab IR, Wang W, Wang J-L (2002) The relationship between first postoperative day epithelial antioxidant status and eventual health of the ocular surface in penetrating keratoplasty. Cornea 21(6):574–577
Holland EJ, Schwartz GS (1999) Epithelial stem-cell transplantation for severe ocular-surface disease. N Eng J Med 340(22):1752–1754
Dua HS, Forrester JV (1990) The corneoscleral limbus in human corneal epithelial wound healing. Am J Ophthalmol 110(6):646–656
Ren H, Wilson G (1996) Apoptosis in the corneal epithelium. Invest Ophthalmol Vis Sci 37(6):1017–1025
Chou L, Cohen EJ, Laibson PR, Rapuano C (1994) Factors associated with epithelial defects after penetrating keratoplasty. Ophthalmic Surg 25(10):700–703
Mathers WD, Lemp MA (1991) Vortex keratopathy of the corneal graft. Cornea 10(2):93–99
Mackman GS, Polack FM, Sydrys L (1983) Hurricane keratitis in penetrating keratoplasty. Cornea 2(1):31–34
Meyer RF, Bobb KC (1980) Corneal epithelium in penetrating keratoplasty. Am J Ophthalmol 90:142–147
Reed DB, Mannis MJ, Hills JF (1987) Corneal epithelial healing after penetrating keratoplasty using topical healon versus balanced salt solution. Ophthalmic Surg 18(7):525–528
Nelson JD, Harvener VR, Cameron JD (1983) Cellulose acetate impressions of the ocular surface: dry eye states. Arch Ophthalmol 101(12):1869–1872
Wilson SE, Kaufman HE (1990) Graft failure after penetrating keratoplasty. Surv Ophthalmol 34(5):325–356
Tseng SCG (1985) Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology 92(6):728–733
Schermer A, Galvin S, Sun T-T (1986) Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol 103(1):49–62
Daniels JD, Dart JG, Tuft SJ, Khaw PT (2001) Corneal stem cells in review. Wound Rep Reg 9(6):483–494
Anderson DF, Ellies P, Pires RT, Tseng SCG (2001) Amniotic membrane transplantation for partial limbal stem cell deficiency. Br J Ophthalmol 85:567–575
Kinoshita S, Friend J, Thoft RA (1981) Sex chromatin of donor epithelium in rabbits. Invest Ophthalmol Vis Sci 21(3):434–441
Kim T, Palay DA, Lynn M (1996) Donor factors associated with epithelial defects after penetrating keratoplasty. Cornea 15(5):451–456
Lindstrom RL, Kaufman HE, Shelnik D (1992) Optisol corneal storage medium. Am J Ophthalmol 114(3):345–356
Wagoner MD, Gonnah E-S (2005) Corneal graft survival after prolonged storage in Optisol-GS. Cornea 24:976–979
Tsubota K, Chiba K, Shimazaki J (1991) Corneal epithelium in diabetic patients. Cornea 10(2):156–160
Thoft RA, Friend J (1976) Corneal epithelial changes during midterm storage. Invest Ophthalmol Vis Sci 15(2):82–88
Mannis MJ, Zadnik K, Miller MR, Marquez M (1997) Preoperative risk factors for surface disease after penetrating keratoplasty. Cornea 16(1):7–11
Deocampo G, Sunga RN (1963) Studies on the epithelialization of corneal grafts with methylene blue. Am J Ophthalmol 56:801–806
Khodadoust AA, Silverstein AM (1969) The survival and rejection of epithelium in experimental corneal transplants. Invest Ophthalmol 8(2):169–179
Shimazaki J, Shimmura S, Mochizuki K, Tsubota K (1999) Morphology and barrier function of the corneal epithelium after penetrating keratoplasty: association with original disease, tear function, and suture removal. Cornea 18(5):559–564
Lemp MA, Mathers WD (1989) Corneal epithelial cell movement in humans. Eye 3(pt 4):438–445
Dana M-R, Schaumberg DA, Kowal BO, Goren MB, Rapuano CJ, Laibson PR, Cohen EJ (1995) Corneal vascularization after penetrating keratoplasty. Cornea 14(6):604–609
Chang J-H, Gabison EE, Kato T, Azar DT (2001) Corneal neovascularization. Opin Ophthalmol 12:242–249
Maguire MG, Stark WJ, Gottsch JD, Stulting RD, Sugar A, Fink NE, Schwartz A (1994) Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Ophthalmology 101(9):1536–1547
Tsubota K (1999) Ocular surface management in corneal transplantation: a review. Jpn J Ophthalmol 43:502–508
Sugar A, Meyer RF, Bahn CF (1983) A randomized trial of pressure patching for epithelial defects after keratoplasty. Am J Ophthalmol 95:637–640
Lambiase A, Rama P, Aloe L, Bonni S (1999) Management of neurotrophic keratopathy. Curr Opin Ophthalmol 10:270–276
Lemp MA (1995) Report of the national eye institute/industry workshop on clinical trials in dry eyes. CLAO J 21:222–232
Sommer A (1998) Xerophthalmia and vitamin A status. Prog Retin Eye Res 17:9–31
Chan RY, Foster CS (1999) A step-wise approach to ocular surface rehabilitation in patients with ocular inflammatory disease. Int Ophthalmol Clin 39(1):83–108
Gulati A, Dana R (2005) Keratoconjunctivitis sicca: clinical aspects. In: Foster CS, Azar DT, Dohlman CH (eds) Smolin and Thoft’s the cornea, scientific foundations and clinical practice. Lippincott Williams & Wilkins, Philadelphia, 603–627
Shimazaki J, Shimmura S, Fujishima H, Tsubota K (2000) Association of preoperative tear function with surgical outcome in severe Stevens-Johnson syndrome. Ophthalmology 107(8):1518–1523
Groden LR, White W (1990) Procine collagen corneal shield treatment of persistent epithelial defects following penetrating keratoplasty. CLAO J 16(2):95–97
Schwartz GS, Holland EJ (2005) Classification and staging of ocular surface disease. In: Krachmer JH, Mannis MJ, Holland EJ (eds) Cornea, Volume 2. Elsevier, Philadelphia, 1794–1796
Nishida K, Kinoshita S, Ohashi Y, Kuwayama Y, Yamamoto S (1995) Ocular surface abnormalities in aniridia. Am J Ophthalmol 120(3):368–375
Wagoner MD, Al-Swailem SA, Sutphin JE, Zimmerman MB. Bacterial keratitis after penetrating keratoplasty: incidence, microbiological profile, graft survival, and visual outcome. Ophthalmology (in press)
Fong LP, Ormerod LD, Kenyon KR, Foster CS (1988) Microbial keratitis complicating penetrating keratoplasty. Ophthalmology 95:1269–1275
Price FW, Whitson WE, Collins KS, Marks RG (1993) Five-year corneal graft survival: a large, single-center patient cohort. Arch Ophthalmol 111:799–805
Holland EJ, Schwartz GS (2000) Changing concepts in the management of severe ocular surface disease over twenty-five years. Cornea 19(5):688–698
Wagoner MD, Al-Swailem MD, Jastaneiah S, Kenyon KR (2007) Chemical injuries of the eye. In: Alber DM, Jacobiec FA (eds) Principles and practice of ophthalmology: clinical practice. Vol 1, ch 72, Saunders, Philadelphia
Di Pascuale MA, Espana EM, Liu DT-S, Kawakita T, Li W, Gao YY, Baradaran-Rafi A, Elizondo A, Raju VK, Scheffer SCG (2005) Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology 112(5):904–912
Tseng SCG, Di Pascuale MA, Liu DT-S, Gao YY, Baradaran-Rafii A (2005) Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases. Ophthalmology 112(5):896–903
Solomon A, Espana EM, Tseng SCG (2003) Amniotic membrane transplantation for reconstruction of the conjunctival fornices. Ophthalmology 110(1):93–100
Tsubota K, Goto E, Shimmura S, Shimazaki J (1999) Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 106(10):1984–1989
Cher I (2003) Blink-related microtrauma: when the ocular surface harms itself. Clin Experiment Ophthalmol 31:183–190
Stern GA, Schemmer GB, Farber RD et al (1983) Effects of topical antibiotic solutions on corneal epithelial wound healing. Arch Ophthalmol 101(4):644–647
Pires RT, Chokshi A, Tseng SCG (2000) Amniotic membrane transplantation or limbal conjunctival autograft for limbal stem cell deficiency induced by 5-fluorouracil in glaucoma surgeries. Cornea 19(3):284–287
Guidera AC, Luchs JI, Udell IJ (2001) Keratitis, ulceration and perforation associated with topical non-steroidal anti-inflammatory drugs. Ophthalmology 108(5):936–944
Gobbels M, Spitznas M (1989) Influence of artificial teas on corneal epithelium in dry-eye syndrome. Graefes Arch Clin Exp Ophthalmol 227:139–141
Anderson DF, Touhami A, Tseng SCG (2001) Limbal stem cell deficiency arising from systemic chemotherapy. Br J Ophthalmol 85:373–374
Hirsh A, Alhalel A, Weiss A et al (1990) Bilateral total corneal epithelial erosion as a side effect of cytotoxic therapy. Br J Ophthalmol 74:638
Puangsricharen V, Tseng SCG (1995) Cytologic evidence of corneal diseases with limbal stem cell deficiency. Ophthalmology 102:1476–1485
Shore JW, Foster CS, Westfall CT, Rubin PA (1992) Results of buccal mucosal grafting for patients with medically controlled ocular cicatricial pemphigoid. Ophthalmology 99:385–395
Calonge M (2001) The treatment of dry eye. Surv Ophthalmol 45:S227–S239
Tai M-C, Cosar CB, Cohen EJ, Rapuano CJ, Laibson PR (2002) The clinical efficacy of silicone punctal plug therapy. Cornea 21(2):135–139
Yokoi N, Komuro A, Nishida K, Kinoshita S (1997) Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye. Br J Ophthalmol 81:533–536
Aragona P, Papa V, Micali A, Santocono M, Milazzo G (2002) Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 86:181–184
Nishida T, Nakamura M, Mishima H et al (1991) Hyaluronan stimulates corneal epithelial migration. Exp Eye Res 53:753–758
Iester M, Orsoni GJ, Gamba G, Taffara M, Mangiafico P, Giuffrida S, Rolando M (2000) Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis. Eye 14(pt 6):892–898
Driver PJ, Lemp MA (1996) Meibomian gland dysfunction. Surv Ophthalmol 40(5):343–367
Shimazaki J, Sakata M, Tsubota K (1995) Ocular surface changes and discomfort in patient with meibomian gland dysfunction. Arch Ophthalmol 113:1266–1270
Tseng SCG, Maumanee E, Stark WJ, Maumenee IH, Jensen AD, Green WR, Kenyon KR (1985) Topical retinoid treatment of various dry-eye disorders. Ophthalmology 92(6):717–727
Murphy PT, Sivakumaran M, Fahy G, Hutchinson RM (1996) Successful use of topical retinoic acid in severe dry eye due to chronic graft-versus-host disease. Bone Marrow Transplant 18(3):641–642
Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M, Tsubota K (2005) The effect of autologous serum eye drops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 139:242–246
Noble BA, Loh RSK, MacLennan S, Pesudovs K, Reynolds A, Bridges LR, Burr J, Stewart O, Quereshi S (2004) Comparison of autologous serum eye drops with conventional therapy in a randomized controlled crossover trial for ocular surface diseases. Br J Ophthalmol 88:647–652
Tananuvat N, Daniell M, Sullivan LJ, Yi Q, McKelvie P, McCarty DJ, Taylor HR (2001) Controlled study of the use of autologous serum in dry eye patients. Cornea 20(8):802–806
Matsumoto Y, Dogru M, Goto E, Ohashi Y, Kojima T, Ishida R, Tsubota K (2004) Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 111(6):1115–1120
Poon AC, Geerling G, Dart JKG, Fraenkel GE, Daniels JT (2001) Autologous serum eye drops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 85:1188–1197
Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, Shimmura S (1999) Treatment of dry eye by autologous serum application in Sjogren’s syndrome. Br J Ophthalmol 83:390–395
Geerling G, MacLennan S, Hartwig D (2004) Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 88:1467–1474
Goto E, Shimmura S, Shimazaki J, Tsubota K (2001) Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 20(8):807–810
Tsubota K, Higuchi A (2000) Serum application for the treatment of ocular surface disorders. Int Ophthalmol Clin 40(4):113–122
Tsubota K, Satake Y, Ohyama M, Toda I, Takano Y, Ono M, Shinozaki N, Shimazaki J (1996) Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 122:38–52
McDonnell PJ, Schanzlin DJ, Rao NA (1988) Immunoglobulin deposition in the cornea after application of autologous serum. Arch Ophthalmol 106:1423–1425
Lagnado R, King AJ, Donald F, Dua HS (2004) A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br J Ophthalmol 88:464–465
Sall K, Stevenson OD, Mundrof TK, Reis BL (2000) Cyclosporin A phase 3 study groups. Two multicenter, randomized studies of the efficacy and safety of cyclosporin ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology 107(4):631–639
Stevenson D, Tauber J, Reis BL (2000) Cyclosporin A phase 2 study groups. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease. Ophthalmology 107(5):967–974
Marsh P, Pflugfelder SC (1999) Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren’s syndrome. Ophthalmology 106:811–816
Anaizi NH, Swenson CF, Dentinger PJ (1997) Stability of acetylcysteine in an extemporaneously compounded ophthalmic solution. Am J Health Syst Pharm 54:549–553
Avisar R, Robinson A, Appel I, Yassur Y, Wenberger D (2000) Diclofenac sodium 0.1% (voltaren ophtha), versus sodium chloride 5% in the treatment of filamentary keratitis. Cornea 9(2):145–147
Tsai R J-F, Tseng SCG (1995) Effect of stromal inflammation on the outcome of limbal transplantation for corneal surface reconstruction. Cornea 14(5):439–449
Tsubota K, Fukagawa K, Fujihara T, Shimmura S, Saito I, Saito K, Takeuchi T (1999) Regulation of human leukocyte antigen expression in human conjunctival epithelium. Invest Ophthalmol Vis Sci 40(1):28–34
Tugal-Tutkun I, Akova YA, Foster CS (1995) Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology 102(4):576–585
Al-Swailem SA (2006) The role of amniotic membrane transplantation in the treatment of chemical injuries of the eye. Middle East J Ophthalmol 13(1):23–38
Barabino S, Rolando M, Bentivoglio G, Mingari C, Zanardi S, Bellomo R, Calabria G (2003) Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid. Ophthalmology 110(3):474–480
Moyes AL, Sugar A, Mushch DC, Barnes RD (1994) Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol 112(5):601–607
Tambasco FP, Cohen EJ, Nguyun LH, Raphano CJ, Laibson PR (1999) Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol 117(4):445–449
Epstein RJ, Stulting RD, Hendricks RL, Harris DM (1987) Corneal neovascularization: pathogenesis and inhibition. Cornea 6:250–257
Pillai CT, Dua HS, Hossain P (2000) Fine needle diathermy occlusion of corneal vessels. Invest Ophthalmol Vis Sci 41:2148–2153
Cursiefen C, Wenkel H, Martus P, Langenbucher A, Nguyen NX, Seitz B, Kuchle M, Naumann GO (2001) Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty. Graefes Arch Clin Exp Ophthalmol 239(7):514–521
Nirankari VS, Baer JC (1986) Corneal argon laser photocoagulation for neovascularization in penetrating keratoplasty. Ophthalmology 93(10):1304–1309
Hao Y, Ma DH, Hwang DG (2000) Identification of antiangiogenic and anti-inflammatory proteins in human amniotic membrane. Cornea 19:348–352
Tseng SC, Prabhasawat P, Barton K et al (1998) Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 116:431–441
Yatoh S, Kawakami Y, Imai M, Kozawa T, Seqawa T, Suzuki H, Yamashita K, Okuda Y (1998) Effect of topically applied neutralizing antibody against vascular endothelial growth factor on corneal allograft rejection of rat. Transplantation 66(11):1519–1524
Patel BC, Sapp NA, Collin R (1998) Standardized range of conformers and symblepharon rings. Ophthal Plast Reconstr Surg 14(2):144–145
Fein W (1979) Repair of total and subtotal symblepharons. Ophthalmic Surg 10:44–47
Chiou AG-Y, Florakis GJ, Kazim M (1998) Management of conjunctival cicatrizing diseases and severe ocular surface dysfunction. Surv Ophthalmol 43(1):19–46
Honavar SG, Bansal AK, Sangwan VS, Rao GN (2000) Amniotic membrane transplantation for ocular surface reconstruction in Stevens-Johnson syndrome. Ophthalmology 107:975–979
Romero-Rangel T, Stavrou P, Cotter J, Rosenthal P, Baltatzis S, Foster CS (2000) Gas-permeable scleral contact lenses therapy in ocular surface disease. Am J Ophthalmol 130(1):25–32
Rosenthal P, Cotter JM, Baum J (2000) Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens. Am J Ophthalmol 130:33–41
West S, Taylor HR (1999) Bilamellar tarsal rotation is the preferred treatment for trachomatous trichiasis. Surv Ophthalmol 43(5):468
Cosar CB, Cohen EJ, Rapuano CJ, Maus M, Penne R, Flanagan JC, Laibson P (2001) Tarsorrhaphy: clinical experience from a cornea practice. Cornea 20(8):787–791
Balent A (1976) An accidental tarsorrhaphy caused by acrylic adhesive. Am J Ophthalmol 82:501
Kirkness CM, Adams GG, Dilliy PN, Lee JP (1988) Botulinum toxin A-induced protective ptosis in corneal disease. Ophthalmology 95(4):473–480
Stamler JF, Tse DT (1990) A simple and reliable technique for permanent lateral tarsorrhaphy. Arch Ophthalmol 108:125–127
Anderson RL, Gordy DD (1979) The tarsal strip procedure. Arch Ophthalmol 97:2192–2196
Kemp EG, Collins JRO (1986) Surgical management of upper eyelid entropion. Br J Ophthalmol 70:575–579
Ti SE, Tow SL, Chee SP (2000) Amniotic membrane transplantation in entropion surgery. Ophthalmology 108:1209–1217
Putterman AM (1980) Combined z-plasty and horizontal shortening procedure for ectropion. Am J Ophthalmol 89:525–530
Vastine DW, Stewart WB, Schwab IR (1982) Reconstruction of the periocular mucous membrane by autologous conjunctival transplantation. Ophthalmology 89:1072–1081
Hill JC (1995) Systemic cyclosporin in high-risk keratoplasty: long term results. Eye 9:422–428
Virender S, Merle F, Aashish B, Geeta V, Gullapalli R (2005) Early results of penetrating keratoplasty following limbal stem cell transplantation. Indian J Ophthalmol 53(1):31–35
Sanwan VS, Matalia HP, Vemuganti GK, Ifthekar G, Fatima A, Singh S, Rao GN (2005) Early results of penetrating keratoplasty after cultivated limbal epithelium transplantation. Arch Ophthalmol 123:334–340
Daya SM, Ilari FA (2001) Living related conjunctival limbal allograft for the treatment of stem cell deficiency. Ophthalmology 108:126–133
Ghoraishi M, Akova YA, Tugal-Tutkun I, Foster CS (1995) Penetrating keratoplasty in atopic keratoconjunctivitis. Cornea 14(6):610–613
Lyons CJ, Dart JKG, Aclimandos WA, Lightman S, Buckley RJ (1990) Scleroscleritis following keratoplasty in atopy. Ophthalmology 97(6):729–733
Samson CM, Nduaguba C, Baltatzis S, Foster CS (2002) Limbal stem cell transplantation in chronic inflammatory eye disease. Ophthalmology 109(5):862–868
Petroutsos G, Drosos A, Pslias K (1992) Repeated melting of corneal grafts in a patient with rheumatoid arthritis and Sjogren’s syndrome. Europ J Ophthalmol 2:36–38
Anderson NJ, Hardten DR, McCarty TM (2003) Penetrating keratoplasty and keratolimbal allograft transplantation for corneal perforations associated with the ectodermal dysplasia syndrome. Cornea 22(4):385–388
Tsubota K, Satake Y, Kaido M, Shinozaki N, Shimmura S, Bissen-Miyajima H, Shimazaki J (1999) Treatment of severe ocular surface disorders with corneal epithelial stem cell transplantation. N Engl J Med 340(22):1697–1703
Holland EJ, Djalilian AR, Schwartz GS (2003) Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique. Ophthalmology 110(1):125–130
Dua HS, Azuara-Blanco A (2000) Autologous limbal transplantation in patients with unilateral corneal stem cell deficiency. Br J Ophthalmol 84:273–278
Kenyon KR, Tseng SCG (1989) Limbal autograft transplantation for ocular surface disorders. Ophthalmology 96(5):709–723
Tan DTH, Ficker LA, Buckley RJ (1996) Ophthalmology 103(1):29–36
Reinhard T, Sundmacher R, Spelsberg H, Althaus C (1999) Homologous penetrating central limbo-keratoplasty (HPCLK) in bilateral limbal stem cell insufficiency. Acta Ophthalmol Scand 77:663–667
Solomon A, Ellies P, Anderson DF, Touhami A, Grueterich M, Espana EM, Ti S-E, Goto E, Feuer WJ, Tseng SCG (2002) Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 109(6):1159–1166
Lambiase A, Rama P, Bonni S, Caprioglio C, Aloe L (1998) Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Eng J Med 338(17):1174–1177
Nishida T, Nakamura M, Ofuji K, Reid TW, Mannis MJ, Murphy CJ (1996) Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea. J Cell Physiol 169(1):159–166
Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L (2000) Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 107(7):1347–1352
Lugo M, Arentsen JJ (1987) Treatment of neurotrophic ulcers with conjunctival flaps. Am J Ophthalmol 103:711–712
Chen HJ, Pires RT, Tseng SCG (2000) Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br J Ophthalmol 84:826–833
Author information
Authors and Affiliations
Corresponding author
Additional information
The author has no commercial or proprietary interest in any of the products or companies presented in this manuscript.
Rights and permissions
About this article
Cite this article
Al-Swailem, S.A. Graft failure: II. Ocular surface complications. Int Ophthalmol 28, 175–189 (2008). https://doi.org/10.1007/s10792-007-9127-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-007-9127-9